Identification and Validation of Stromal Immunotype Predict Survival and Benefit from Adjuvant Chemotherapy in Patients with Muscle-Invasive Bladder Cancer

Hangcheng Fu, Yu Zhu, Yiwei Wang, +7

Clinical Cancer Research

Tumor-associated Macrophage-derived Interleukin-23 Interlinks Kidney Cancer Glutamine Addiction with Immune Evasion

Qiang Fu, Le Xu, Yiwei Wang, +17

European Urology

Tumor BiologyImmune EvasionCytokineCancer ImmunosurveillanceMedicine +8

Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancer

Zheng Liu, Yu Zhu, Le Xu, +7

OncoImmunology

Tumor Infiltrating Mast Cells (TIMs) Confers a Marked Survival Advantage in Nonmetastatic Clear-Cell Renal Cell Carcinoma

Hangcheng Fu, Yu Zhu, Yiwei Wang, +7

Annals of Surgical Oncology

UrologySurgical OncologyCancer ImmunosurveillanceGenitourinary CancerPathology +4

Galectin-9 predicts postoperative recurrence and survival of patients with clear-cell renal cell carcinoma

Hangcheng Fu, Yidong Liu, Le Xu, +5

Tumor Biology

CCL2/CCR2 axis is associated with postoperative survival and recurrence of patients with non-metastatic clear-cell renal cell carcinoma

Zewei Wang, Huyang Xie, Lin Zhou, +5

Oncotarget

Prognostic value of interleukin-6 and interleukin-6 receptor in organ-confined clear-cell renal cell carcinoma: a 5-year conditional cancer-specific survival analysis

Qiang Fu, Yuan Chang, Huimin An, +5

British Journal of Cancer

Increased B4GALT1 expression associates with adverse outcome in patients with non-metastatic clear cell renal cell carcinoma

Huyang Xie, Yu Zhu, Huimin An, +7

Oncotarget

Increased expression of MUC3A is associated with poor prognosis in localized clear-cell renal cell carcinoma

Tian Niu, Yidong Liu, Yuan Zhang, +6

Oncotarget

Tumor BiologyUrologyOncologyGenitourinary CancerMedicine +9

Galectin-9 as a prognostic and predictive biomarker in bladder urothelial carcinoma

Yidong Liu, Zheng Liu, Qiang Fu, +5

Urologic Oncology Seminars and Original Investigations

Prognostic BiomarkersUrologyUrological ResearchGenitourinary CancerPathology +6